Construction work on Leiden Vaccine Manufacturing Facility located in Leiden, South Holland, Netherlands commenced in Q2 2023, after the project was announced in Q2 2022. According to GlobalData, who tracks and profiles more than 220,000 major construction projects from announcement to completion, the project is expected to be completed by Q3 2024. To learn more about the Leiden Vaccine Manufacturing Facility project, buy the profile here.
The project involves the construction of a 12,000m2 vaccine manufacturing plant with six production suites in Leiden, South Holland, Netherlands.
Smarter leaders trust GlobalData
The project includes the following:
1. Construction of laboratory
2. Construction of a production unit
3. Construction of an administrative office
4. Construction of a distribution unit,
5. Construction of research facilities
6. Construction of a warehouse
7. Installation of machinery
8. Installation of equipment and
9. Installation of safety and security systems
Construction on the project is expected to be completed by Q3 2024.
The Netherlands-based Paul de Ruiter is the architect and engineering design consultant for the Leiden Vaccine Manufacturing Facility, while Municipality of Leiden is the planning authority.
For more details on the Leiden Vaccine Manufacturing Facility project, buy the profile here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying research used to produce this article.
GlobalData’s Construction Projects database tracks over 220,000 new construction projects valued at >$25m from announcement to completion across all countries and sectors.
